Literature DB >> 21145263

Seizure in people with newly diagnosed active or transitional neurocysticercosis.

Elizabeth A Kelvin1, Arturo Carpio, Emilia Bagiella, Denise Leslie, Pietro Leon, Howard Andrews, W Allen Hauser.   

Abstract

PURPOSE: The aim of this study is to describe seizure as a presenting symptom in individuals with recently diagnosed neurocysticercosis (NCC).
METHODS: Using logistic regression, we examined the probability of having seizures as a presenting symptom among those with active or transitional NCC by host age and gender, and by number of cysts, location of the cysts in the brain, and phase of evolution of the encysted parasite.
RESULTS: We found that the odds of having seizures as presenting symptom for those in the youngest age group (3-24 years old) were 12.9 times that of the oldest participants (age 55-82 years) (p=0.006). People with cysts in parenchymal locations had a significantly higher odds of seizures compared to those with all their cysts elsewhere (ventricles or subarachnoid) (OR=6.2, p=0.028); and the number of cysts was significantly associated with having seizures (OR=1.1, p=0.026). Host gender and cyst phase were not significantly associated with having seizures after adjusting for confounders and covariates.
CONCLUSION: Children, those with cysts in parenchymal locations, and those with a higher number of cysts appear to be more likely to experience seizure when they have NCC cysts in the active or transitional stage.
Copyright © 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21145263      PMCID: PMC3057662          DOI: 10.1016/j.seizure.2010.10.036

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  29 in total

1.  Neurocysticercosis: clinical, radiologic, and inflammatory differences between children and adults.

Authors:  Brenda Sáenz; Matilde Ruíz-Garcia; Enedina Jiménez; Juan Hernández-Aguilar; Roberto Suastegui; Carlos Larralde; Edda Sciutto; Agnès Fleury
Journal:  Pediatr Infect Dis J       Date:  2006-09       Impact factor: 2.129

Review 2.  Neurocysticercosis: management issues.

Authors:  Tarun Dua; S Aneja
Journal:  Indian Pediatr       Date:  2006-03       Impact factor: 1.411

Review 3.  Taenia solium disease in humans and pigs: an ancient parasitosis disease rooted in developing countries and emerging as a major health problem of global dimensions.

Authors:  E Sciutto; G Fragoso; A Fleury; J P Laclette; J Sotelo; A Aluja; L Vargas; C Larralde
Journal:  Microbes Infect       Date:  2000-12       Impact factor: 2.700

Review 4.  Taenia solium cysticercosis.

Authors:  H H Garcia; O H Del Brutto
Journal:  Infect Dis Clin North Am       Date:  2000-03       Impact factor: 5.982

5.  A proposal for classification of neurocysticercosis.

Authors:  A Carpio; M Placencia; F Santillán; A Escobar
Journal:  Can J Neurol Sci       Date:  1994-02       Impact factor: 2.104

Review 6.  Clinical aspects of neurocysticercosis.

Authors:  Osvaldo M Takayanagui; Newton Satoru Odashima
Journal:  Parasitol Int       Date:  2005-12-05       Impact factor: 2.230

7.  Post-traumatic seizures-A prospective study from a tertiary level trauma center in a developing country.

Authors:  Amit Thapa; Sarat P Chandra; Sumit Sinha; V Sreenivas; Bhawani S Sharma; Manjari Tripathi
Journal:  Seizure       Date:  2010-03-03       Impact factor: 3.184

Review 8.  Treatment of neurocysticercosis: current status and future research needs.

Authors:  T E Nash; G Singh; A C White; V Rajshekhar; J A Loeb; J V Proaño; O M Takayanagui; A E Gonzalez; J A Butman; C DeGiorgio; O H Del Brutto; A Delgado-Escueta; C A W Evans; R H Gilman; S M Martinez; M T Medina; E J Pretell; J Teale; H H Garcia
Journal:  Neurology       Date:  2006-10-10       Impact factor: 9.910

9.  Outcomes of medical treatment of neurocysticercosis: a study of 65 cases in Cheju Island, Korea.

Authors:  S K Kim; K C Wang; S H Paek; K S Hong; B K Cho
Journal:  Surg Neurol       Date:  1999-12

10.  Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial.

Authors:  A Carpio; E A Kelvin; E Bagiella; D Leslie; P Leon; H Andrews; W A Hauser
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-05-21       Impact factor: 10.154

View more
  7 in total

1.  The effect of albendazole treatment on non-seizure outcomes in patients with symptomatic neurocysticercosis.

Authors:  Kriti Thapa; Matthew L Romo; Arturo Carpio; Denise Leslie; Howard Andrews; W Allen Hauser; Elizabeth A Kelvin
Journal:  Trans R Soc Trop Med Hyg       Date:  2018-02-01       Impact factor: 2.184

2.  Exploring the complex associations over time among albendazole treatment, cyst evolution, and seizure outcomes in neurocysticercosis.

Authors:  Arturo Carpio; Mindy Chang; Hongbin Zhang; Matthew L Romo; Alex Jaramillo; W Allen Hauser; Elizabeth A Kelvin
Journal:  Epilepsia       Date:  2019-07-29       Impact factor: 5.864

3.  Prevalence, Response to Cysticidal Therapy, and Risk Factors for Persistent Seizure in Indian Children with Neurocysticercosis.

Authors:  Animesh Kumar; Anirban Mandal; Sheela Sinha; Amitabh Singh; Rashmi Ranjan Das
Journal:  Int J Pediatr       Date:  2017-01-10

4.  Neurocysticercosis in Northern Peru: Qualitative Insights from men and women about living with seizures.

Authors:  Maria Amalia Pesantes; Luz Maria Moyano; Claire Sommerville
Journal:  PLoS Negl Trop Dis       Date:  2020-10-09

5.  Community-level prevalence of epilepsy and of neurocysticercosis among people with epilepsy in the Balaka district of Malawi: A cross-sectional study.

Authors:  Luise Keller; Dominik Stelzle; Veronika Schmidt; Hélène Carabin; Ann-Kristin Reinhold; Claudius Keller; Tamara M Welte; Vivien Richter; Action Amos; Lindsay Boeckman; Wendy Harrison; Andrea S Winkler
Journal:  PLoS Negl Trop Dis       Date:  2022-09-15

Review 6.  Unique Characteristics of Epilepsy Development in Neurocysticercosis.

Authors:  Jesica A Herrick; Javier A Bustos; Philip Clapham; Hector H Garcia; Jeffrey A Loeb
Journal:  Am J Trop Med Hyg       Date:  2020-05-14       Impact factor: 2.345

Review 7.  Epileptogenesis in Common Parasitic Infections.

Authors:  Rajarshi Mazumder; John K Lee
Journal:  Curr Neurol Neurosci Rep       Date:  2022-03-25       Impact factor: 6.030

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.